Redox-Active Drug, MnTE-2-PyP5+, Prevents and Treats Cardiac Arrhythmias Preserving Heart Contractile Function

Background. Cardiomyopathies remain among the leading causes of death worldwide, despite all efforts and important advances in the development of cardiovascular therapeutics, demonstrating the need for new solutions. Herein, we describe the effects of the redox-active therapeutic Mn(III) meso-tetrak...

Full description

Bibliographic Details
Main Authors: Andrezza M. Barbosa, José F. Sarmento-Neto, José E. R. Menezes Filho, Itamar C. G. Jesus, Diego S. Souza, Valério M. N. Vasconcelos, Fagner D. L. Gomes, Aline Lara, Juliana S. S. Araújo, Sandra S. Mattos, Carla M. L. Vasconcelos, Silvia Guatimosim, Jader S. Cruz, Ines Batinic-Haberle, Demetrius A. M. Araújo, Júlio S. Rebouças, Enéas R. Gomes
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Oxidative Medicine and Cellular Longevity
Online Access:http://dx.doi.org/10.1155/2020/4850697